Overview

Phase I/II Trial of Antagonism of HER in GI Cancer

Status:
Completed
Trial end date:
2019-08-02
Target enrollment:
Participant gender:
Summary
Recruitment to phase I of the PANTHER trial is complete. Phase II, is to evaluate the best overall response rate for AZD8931 + FOLFIRI treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University College, London
Collaborators:
AstraZeneca
Cancer Research UK
National Institute for Health Research, United Kingdom
Treatments:
Fluorouracil
Folic Acid
Irinotecan
Leucovorin
Levoleucovorin